Fig. 8From: CRISPR/Cas12a-based on-site diagnostics of Cryptosporidium parvum IId-subtype-family from human and cattle fecal samplesValidation of ReCTC-based detection of C. parvum IId SF in positive clinical human samples. Clinical human fecal DNA samples collected from inpatients that had been identified as positive for C. parvum IIdA19G1 were subjected to a ReCTC-based fluorescence and b LFS detection. N negative controlBack to article page